Heijmans N.V. (0M6I) Gets a Buy from Kepler Capital
Kepler Capital analyst Tim Ehlers maintained a Buy rating on Heijmans N.V. (0M6I – Research Report) on March 13 and set a price target of ...
COSMO Pharmaceuticals N.V. (0RGI) Receives a Buy from Kepler Capital
In a report released on March 13, Nicolas Pauillac from Kepler Capital maintained a Buy rating on COSMO Pharmaceuticals N.V. (0RGI – Research ...